Achelous Partners is an independent investment bank known internationally for advising on Mergers and Acquisitions and crafting innovative financial and strategic solutions for clients globally. Based in New York, we specialize in serving a substantial global client base of life science and healthcare companies led by a senior team of M&A specialists with significant industry expertise.
Since its inception in 1999, our firm has earned a reputation for building long-term client relationships by assisting numerous public and private companies achieve their complex financial and strategic goals. We assist our clients by providing a specialized range of investment banking services, most notably cross-border Mergers & Acquisitions. In 2004, Achelous Partners was named Frost & Sullivan Pharmaceuticals Buy-Side M&A Advisor of the Year for the creation of ChemGenex Pharmaceuticals (NASDAQ: CXSP), the merger of an Australian public genomics company and a California-based private cancer drug development company.
Our M&A and corporate finance expertise are enhanced by our team’s thorough understanding of the healthcare and biotechnology sector demonstrated by our bankers’ career backgrounds and deep industry relationships. We are focused on grasping the key value drivers of the international life science community in order to identify and evaluate creative strategic opportunities for various international clients. Our ability to access US capital markets as a licensed FINRA broker-dealer further enables our clients to leverage M&A as a valuable strategic tool.
Our team is dedicated to creating value for our clients through transformational transactions and we seek to continue growing our reputation as a leading global M&A specialist in the healthcare and biotechnology sector. Achelous Partners is a licensed FINRA broker-deale